Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Cash from Investing Activities (2019 - 2026)

Nurix Therapeutics (NRIX) has disclosed Cash from Investing Activities for 8 consecutive years, with -$123.8 million as the latest value for Q1 2026.

  • Quarterly Cash from Investing Activities fell 584.96% to -$123.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Feb 2026, up 99.44% year-over-year, with the annual reading at $147.9 million for FY2025, 157.37% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$123.8 million at Nurix Therapeutics, down from $346000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $71.5 million in Q2 2025, with the low at -$140.8 million in Q4 2024.
  • Average Cash from Investing Activities over 5 years is -$8.1 million, with a median of $16.1 million recorded in 2023.
  • The sharpest move saw Cash from Investing Activities surged 1777.04% in 2022, then crashed 879.73% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $55.0 million in 2022, then crashed by 126.13% to -$14.4 million in 2023, then plummeted by 879.73% to -$140.8 million in 2024, then soared by 100.25% to $346000.0 in 2025, then tumbled by 35887.86% to -$123.8 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$123.8 million, $346000.0, and $50.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.